INS and metabolic syndrome: For example, ROS associated with several abnormalities, such as hyperglycemia, non-enzymatic glycosylation, inflammation and/or dyslipidemia, may cause decreased insulin expression and/or an impaired response to the insulin signal [[11], [12], [13]].